Philochem is happy to announce the start of an Innosuisse collaboration with the Department of Neurology at the University Hospital and University of Zurich. During the collaboration, both teams will explore the usage of novel Immunocytokines for the treatment of brain tumors in preclinical mouse models facilitating the development of novel brain tumor therapies.


Philochem will be attending the 10th World ADC Conference in London (United Kingdom) from March 2 to 5, 2020
10th World ADC London
Dr. Samuele Cazzamalli will give a plenary lecture on: “Small Molecule-DrugConjugates: Getting small to enhance targeting”
Jacopo Millul will give a presentation on: “Encoded Self-Assembling Chemical Libraries for the Discovery of New Small Molecules for Tumour-Associated Antigens”

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.

I Accept Cookie Policy